Daniel Weiss, Senior Editor, Pharmacy Times

The court's decision makes it more likely that generic versions of medications will be made available before their patents expire and will likely lead to reduced drug costs for consumers.

The court will decide whether "pay-to-delay" arrangements, in which the manufacturer of a branded medication pays another company to keep a generic version off the market, are legal.

A child born to a mother infected with HIV and aggressively treated with antiretroviral therapy starting shortly after birth appears to have been cured of HIV.